MarketPulse

tumor treatment

2 articles
BenzingaBenzinga··Prnewswire

IceCure Medical to Release 2025 Results March 17, Signaling Year-End Performance Review

IceCure Medical will report 2025 full-year results March 17, 2026, before market open, with a conference call at 11:00 a.m. EDT.
ICCMfinancial resultsearnings announcement
BenzingaBenzinga··Prnewswire

IceCure's Cryoablation Wins Independent Validation for Breast Fibroadenomas

IceCure's ProSense cryoablation achieved 92.9% volume reduction in independent breast fibroadenoma study, validating technology for a 63,000-patient annual U.S. market.
ICCMmedical deviceminimally invasive surgery